Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

ABO: A 3D stroma-supported culture platform enabling full human B-lymphopoiesis for disease modeling and gene therapy development.

Cell reports. Medicine·2026

Same author

At least 3 different progenitors with BM counterparts seed the thymus.

The Journal of allergy and clinical immunology·2026

Same author

Interleukin-6 restricts pre-thymic T cell lineage commitment of progenitors driving loss of SIV control.

bioRxiv : the preprint server for biology·2026

Same author

Cascade Testing Among Patients With Breast Cancer: Current Situation and Challenges in Latin America.

JCO global oncology·2025

Same author

<i>Ex vivo-</i>generated lymphoid progenitors encompass both T cell and innate lymphoid cell fates.

Frontiers in immunology·2025

Same author

Navigating disruption in the PID landscape: embracing opportunities and anticipating threats in the next ten years.

Frontiers in immunology·2025

Same journal

Oncolytic virus-delivered GSDME: Unlocking pyroptosis to improve dendritic cell function and amplify cytotoxic T cell response.

Molecular therapy. Oncology·2026

Same journal

Natural killer cell-derived extracellular vesicles reprogram cellular human immunity to enhance tumor cytotoxicity.

Molecular therapy. Oncology·2026

Same journal

PARP7 inhibitors enhance the immunogenic effects of radiation in pancreatic cancer cells.

Molecular therapy. Oncology·2026

Same journal

Patient-derived tumor organoids for personalized cancer immunotherapy: An immunopeptidome-to-validation approach in RCC and BC.

Molecular therapy. Oncology·2026

Same journal

Development of chimeric antigen receptors targeting the γδ T cell receptor.

Molecular therapy. Oncology·2026

Same journal

Tumoricidal efficacy of DZ-1 dye conjugated to dihydroartemisinin in patient-derived colorectal liver metastasis tumoroids.

Molecular therapy. Oncology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 28, 2025

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

Driving CAR-T cells toward solid lung tumors

Frank J T Staal¹, Federico Avila-Moreno²

¹Laboratory for Stem Cell Biology and Lymphocyte Development, Department of Immunology, L3-35, Department of Pediatrics, Leiden University Medical School (LUMC), Leiden, the Netherlands.

Molecular Therapy. Oncology

|April 10, 2024

Summary

No abstract available in PubMed .

More Related Videos

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

A Spheroid Killing Assay by CAR T Cells

A Spheroid Killing Assay by CAR T Cells

Published on: December 12, 2018

Related Experiment Videos

Last Updated: Jun 28, 2025

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

A Spheroid Killing Assay by CAR T Cells

A Spheroid Killing Assay by CAR T Cells

Published on: December 12, 2018